00069-1501 Talzenna - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00069-1501

Brand Name:

Talzenna

Generic Name:

Talazoparib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: TALAZOPARIB TOSYLATE

Strength: 0.5

Unit: mg/1

Packages:

Code: 00069-1501-30

Description: 1 BOTTLE in 1 CARTON (0069-1501-30) / 30 CAPSULE in 1 BOTTLE

Effective Date: Jan. 31, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

PARP

Orphan Drug Designation:

Status:

In Use